Your doctor will evaluate metabolic risks, heart disease history, and other conditions before prescribing
You may typically experience those when starting the medication or increasing the dose
Weight Management in Hyperthyroid Patients Hyperthyroidism often leads to weight loss due to an increased metabolic rate
Bij Peptidesvoordelig.nl leveren wij uitsluitend zorgvuldig geselecteerde research peptides voor gebruik binnen gecontroleerde onderzoeksomgevingen
Your doctor should know if you have a history of: Pancreatitis (acute or chronic)both medications carry warnings about pancreatitis risk Severe gastrointestinal disease , including gastroparesis, which may be exacerbated by GLP-1-based therapies Renal impairment sitagliptin requires dose adjustment based on eGFR, while tirzepatide does not require dose adjustment, though caution is advised with dehydration Thyroid disease Mounjaro's UK SmPC notes that rodent studies showed an increased incidence of thyroid C-cell tumours, though the relevance to humans is unknown
Your provider can help determine how many months of therapy align with your fertility timeline and health goals
